Nicole Baranda Balmaceda, Gastrointestinal Oncologist, Assistant Professor at MD Anderson Cancer Center, shared a post on X:
“Is HER2 therapy the answer for HER2-mutated non-amp GI cancers? Check out our GI26 abstract. Coexisting HER2 mutations may have a negative impact on HER2 tx efficacy in amp non-esophagogastric GI cancers. Also, congrats to my amazing mentor Sunnie Kim on chairing a great session!”
More posts featuring Nicole Baranda Balmaceda.